Soaring Demand Set to Propel Implantable Cardioverter Defibrillators (ICDs) Market to $4.95 Billion by 2029

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Implantable Cardioverter Defibrillators (ICDs) Market Through 2025?
The market valuation for implantable cardioverter defibrillators (ICDs) has experienced substantial expansion over the past few years, projecting an increase from $3.76 billion in 2024 to reach $3.98 billion by 2025, reflecting a compound annual growth rate (CAGR) of 5.8%; this upward trajectory during the review period is largely fueled by a greater frequency of sudden cardiac arrest events, the integration of ICDs into protocols for the secondary prevention of sudden cardiac arrest, heightened public consciousness regarding heart health, demographic shifts towards an older population, favorable regulatory frameworks from governmental and health bodies, and improved availability of medical services.

What's the Projected Size of the Global Implantable Cardioverter Defibrillators (ICDs) Market by 2029?
The market for implantable cardioverter defibrillators anticipates robust expansion across the coming years, projected to reach a valuation of $4.95 billion by 2029, driven by a compound annual growth rate (CAGR) of 5.6%. This upward trajectory during the forecast interval is underpinned by several factors, including the increasing adoption of implantable defibrillators, a heightened need for highly customized cardiac treatments, the escalating incidence of cardiac rhythm abnormalities, and burgeoning demand originating from developing economies. Significant movements shaping this market throughout the forecast include ongoing technological refinements, the launch of subcutaneous ICDs that eliminate the need for transvenous leads, a push for combined ICD and pacemaker units, improvements in algorithms for sensing and detection, continuous progress in wire-free charging solutions and battery science, and the incorporation of artificial intelligence and data analysis within the healthcare sector.

View the full report here:
https://www.thebusinessresearchcompany.com/report/implantable-cardioverter-defibrillators-icds-global-market-report

Top Growth Drivers in the Implantable Cardioverter Defibrillators (ICDs) Industry: What's Accelerating the Market?
A surge in the occurrence of ailments affecting the heart and circulatory system is anticipated to fuel the expansion of the market for internally placed electrical devices that restart the heart, known as implantable cardioverter defibrillators (ICDs). These circulatory system disorders, which encompass issues like cardiac infarctions, cerebral vascular accidents, and elevated blood pressure-often stemming from suboptimal nutrition, insufficient physical activity, tobacco use, and inherited predispositions-are becoming more widespread. The primary reason for the greater frequency of these heart and vessel conditions involves demographic shifts toward older age groups, contemporary patterns of unhealthy living, and an escalation in contributing risk elements such as excessive weight, diabetes mellitus, and hypertension. The devices in question, ICDs, function to control these cardiac issues by delivering necessary electrical jolts to correct abnormal cardiac electrical activity in individuals susceptible to abrupt cessation of heart function. To illustrate this trend, official data from the Australian Institute of Health and Welfare, an agency of the Australian government, indicated that in December 2023, fatalities officially recognized as resulting from coronary heart disease moved up to 14,100 cases in the year 2021, climbing again to 14,900 instances throughout 2022; consequently, the escalating incidence of cardiovascular pathologies serves as a catalyst for the upward trajectory of the ICDs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20839&type=smp

What Trends Will Shape the Implantable Cardioverter Defibrillators (ICDs) Market Through 2029 and Beyond?
Key players within the implantable cardioverter defibrillators (ICDs) sector are heavily prioritizing innovation in technology, particularly the development of defibrillators that use less electrical current, with the goals of boosting device efficiency, lengthening battery longevity, and increasing patient ease. These energy-efficient defibrillators aim to administer necessary heart shocks with reduced power usage, thereby extending the operational lifespan of the battery while maintaining efficacy in treating erratic heart rhythms. To illustrate this, in October of 2023, MicroPort CRM, a medical technology firm situated in France, introduced both the ULYS implantable cardioverter defibrillator (ICD) and the INVICTA defibrillation lead into the Japanese market, signifying a considerable step forward in cardiac treatment technology. These introduced products boast cutting-edge features, including reduced energy draw for extended battery performance and compatibility with Magnetic Resonance Imaging (MRI) procedures, making them appropriate for individuals requiring such diagnostic scans. Specifically incorporating the PARAD+ algorithm for better arrhythmia identification and AutoMRI functionality, the ULYS ICD improves patient security during MRI examinations; furthermore, the INVICTA lead demonstrated strong clinical performance, recording a perfect 100% success rate upon implantation and incurring complications in only 2.6% of cases, underscoring its dependability and proven capability.

What Are the Main Segments in the Implantable Cardioverter Defibrillators (ICDs) Market?
The implantable cardioverter defibrillators (icds)market covered in this report is segmented -

1) By Type: Single Chamber Implantable Cardioverter Defibrillators (ICDs); Dual Chamber Implantable Cardioverter Defibrillators (ICDs); Biventricular Devices
2) By Applications: Bradycardia; Tachycardia; Heart Failure; Other Applications
3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users

Subsegments:
1) By Single Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Single Chamber ICDs; MRI-Compatible Single Chamber ICDs; Wireless Single Chamber ICDs
2) By Dual Chamber Implantable Cardioverter Defibrillators (ICDs): Standard Dual Chamber ICDs; MRI-Compatible Dual Chamber ICDs; Wireless Dual Chamber ICDs
3) By Biventricular Devices: CRT-D (Cardiac Resynchronization Therapy Defibrillator); CRT-P (Cardiac Resynchronization Therapy Pacemaker); Biventricular ICDs With Advanced Features (Remote Monitoring, Wireless Capabilities)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20839&type=smp

Which Top Companies are Driving Growth in the Implantable Cardioverter Defibrillators (ICDs) Market?
Major companies operating in the implantable cardioverter defibrillators (ICDs) market are Abbott Laboratories, Medtronic Inc., Koninklijke Philips N.V., Boston Scientific Corporation, ZOLL Medical Corporation, St. Jude Medical Inc., BIOTRONIK SE & Co. KG, Nihon Kohden Corporation, Fukuda Denshi Co. Ltd., LivaNova PLC, MicroPort Scientific Corporation, Japan Lifeline Co. Ltd., AtriCure Inc., Physio-Control Inc., BPL Medical Technologies Private Limited, Kestra Medical Technologies Inc., CU Medical Germany GmbH, Metrax GmbH, Intermedics Inc., Sorin Group S.p.A.

Which Regions Will Dominate the Implantable Cardioverter Defibrillators (ICDs) Market Through 2029?
North America was the largest region in the implantable cardioverter defibrillators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable cardioverter defibrillators (ICDs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20839

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.